Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy

Int J Pharm. 2019 Oct 30:570:118663. doi: 10.1016/j.ijpharm.2019.118663. Epub 2019 Sep 4.

Abstract

Nanoformulations with advantages in drug delivery, safety and pharmacodynamics have been booming as a promising strategy for cancer therapy. However, the traditional nanocarrier still suffers from the low drug loading capacity, potential systematic toxicity, unclear metabolism, and other uncertainties. To overcome these issues, carrier-free nanodrugs with desirable bioactivity were developed rapidly and drawn considerable attention. Meanwhile, the multifunctional self-delivery nanoarcheticture fabricated by a simple and "green" method, has significant advantages in synergistic cancer therapy and inhibition of multidrug resistant (MDR). Till now, carrier-free nanoparticles for tumor theranostics, phototherapy, chemotherapy, diagnose and synergistic therapy, have made outstanding progress. In this review, we make an integrated and exhaustive overview of lately reports on carrier-free nanodrug delivery systems formed by several active agents. We summarize the self-assembly and modified strategies, with emphasis on application superiority of carrier-free nanocrystal, and give new insight into the establishment of ideal nanosystems for cancer treatment.

Keywords: Carrier-free; Nanodrug; Self-assembly; Synergistic cancer therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Drug Carriers / chemistry*
  • Drug Delivery Systems / methods
  • Drug Resistance, Multiple / drug effects
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Drug Carriers